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ABSTRACT
Background    To evaluate the detectability of arterial 
acute thrombus on R2* map by iterative decomposition 
of water and fat with echo asymmetry and least-squares 
estimation (IDEAL) IQ compared with T2*-weighted 
imaging (T2*WI). 
Methods    Twenty-six patients with acute cerebral 
infarction who underwent R2* map and T2*WI were 
reviewed. We performed visual assessment of each se-
quence regarding the visibility of susceptibility effect 
reflecting acute thrombus and quantitative evaluation of 
the thrombus on R2* map.
Results    Both R2* map and T2*WI showed suscepti-
bility effect reflecting acute thrombi at the occluded site 
of magnetic resonance angiography (MRA) in 9 patients. 
R2* map revealed positive while T2*WI showed equiv-
ocal findings in 3 patients due to the surrounding vessel 
signal intensity. Acute thrombus at distal internal carotid 
artery (ICA) on R2* map was more clearly detected 
than that on T2*WI without any apparent susceptibility 
artifact from the skull base in 4 patients. Most of cardio-
genic embolic infarction (CEI) and artery-to-artery em-
bolic infarction (A-to-A) demonstrated positive and most 
of atherothrombotic infarction (ATI) revealed negative 
findings on R2* map, although quantitative R2* values 
of thrombi did not show significant differences between 
CEI (136.6 /msec) and A-to-A (189.9 /msec) (P = 0.332). 
Conclusion    The detectability of acute thrombus on 
R2* map is comparable to that on T2*WI. Regarding 
thrombus at distal ICA, its detectability on R2* map is 
superior to that on T2*WI. R2* map provide additional 
information to distinguish between embolic and athero-
thrombotic infarctions.
Key words    central nervous system; embolism/throm-
bosis; ischemia/infarction; magnetic resonance imaging
Magnetic resonance (MR) imaging plays an important 
role for acute cerebral infraction to investigate the pres-
ence of ischemic lesion, ischemic penumbra and hem-
orrhagic complication.1–6 In addition, it is important to 
recognize the causes of infarction including cardiogenic 
embolism, atherosclerotic infarction, and lacunar infarc-
tion as early as possible because therapeutic strategies 
are different depending on each pathophysiology.1, 2
 T2*-weighted imaging (T2*WI) is a useful MR 
sequences that enable to detect susceptibility effects 
such as hemorrhage, calcifications, venous structures in-
cluding tissue ischemic sign and acute emboli with high 
sensitivity.6–10 Recently, evaluating susceptibility effect 
of intra-arterial acute thrombus as susceptibility vessel 
sign is considered to be critical because location, size, or 
signal intensity of susceptibility vessel sign on T2*WI 
are the important factors to predict the effectiveness of 
thrombolytic therapy by intravenous recombinant tissue 
plasminogen activator (rtPA) and mechanical thrombec-
tomy with endovascular procedure.11–15
 Although T2*WI has an advantage of detecting 
acute thrombi as previously reported, it also has a 
well-established drawback of this sequence. The image 
of T2*WI near the skull base can be distorted because 
of the strong susceptibility artifact, which may decrease 
the detectability of susceptibility sign near the skull 
base, such as distal internal carotid artery (ICA), bas-
ilar-top and proximal posterior cerebral artery (PCA) 
segments.10–13
 On the other hand, a newly developed multi-echo re-
construction technique, called R2* map, is an algorithm 
based on 6-point Dixon method, which can correct T2* 
decay and eddy currents induced phase errors.16–18 R2* 
map can generate quantitative susceptibility-sensitive 
image and we hypothesize that R2* map will have a po-
tential to detect acute thrombus with high accuracy.
 The purpose of the present study is to evaluate the 
detectability of arterial fresh thrombus on R2* map 
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compared with conventional T2*WI in the patients with 
acute cerebral infarction. To our knowledge, there were 
only a few investigations to refer to the usefulness of 
R2* map in the central nervous system disorders,19, 20 
and this is the first report to examine the utility of R2* 
map in acute cerebral infarction.
MATERIALS AND METHODS
Patients
This retrospective study analyzed data obtained from all 
patients with a stroke admitted to our institution between 
April 2, 2013 and September 30, 2014. Patients were el-
igible if they met the following criteria: MR imaging in-
cluding diffusion weighted imaging (DWI), T2*WI, R2* 
map by iterative decomposition of water and fat with 
echo asymmetry and least-squares estimation (IDEAL) 
IQ and 3 dimensional time of flight MR angiography 
(MRA) performed, at least one occluded intracranial 
vessel on initial MRA, and cause of brain infarction 
with intracranial vessel occlusion confirmed from clini-
cal information. Our institutional review board approved 
this study (approval number 2582), and waived the need 
for written informed consent because of its retrospective 
design.
Imaging examinations
All MR examinations were performed using a 3T MR 
system (Discovery MR750w 3.0 T, GE Healthcare, 
Milwaukee, WI). R2* map is one of the sequences gen-
erated by single scanning of IDEAL IQ. Each scanning 
parameter of IDEAL IQ for R2* map, T2*WI, DWI and 
MRA was as follows: IDEAL IQ: repetition time (TR), 
8.3 ms; echo time (TE), six different echoes ranging 
from 1.2 to 7.2 ms; field of view (FOV), 21 cm; matrix, 
256 × 256; slice thickness, 2.0 mm, acquisition time, 1 
min 47 s. T2*WI: TR, 600 ms; TE, 18 ms; FOV, 21 cm; 
matrix, 512 × 512; slice thickness, 5.0 mm; acquisition 
time, 1 min 5 s. DWI: TR, 7,000 ms; FOV, 21 cm; ma-
trix, 128 × 128; slice thickness, 5.0 mm. MRA: TR, 20 
ms; TE, 3.4 ms; FOV, 20 cm; matrix, 384 × 224; slice 
thickness, 1.0 mm.
Table 1. The summary of clinical data and the results of our study in 26 patients
Patient Age (years)/sex
Interval between initial MR imag-
ing and symptom onset (hours)
Cause of brain 
infarction
Imaging findings Mean R2* 
value 
(/msec)
Affected vessel on 
MRA T2*WI R2* map
1 81/M 7 CEI Rt. terminal ICA Positive Positive 147.78
2 89/F 2.5 CEI Lt. terminal ICA Not evaluable Positive 240.9
3 70/M 3 CEI Lt. ICA Not evaluable Positive 269.26
4 80/F 6 CEI Rt. M1 Positive Positive 169.95
5 82/M 6 CEI Rt. M1 Negative Negative –
6 82/M 1.5 CEI Lt. M1 Equivocal Positive 142.36
7 76/F 3.5 CEI Rt. M2 Positive Positive 107.08
8 86/F 6 CEI Rt. M2 Positive Positive 66.39
9 93/F 8 CEI Rt. M2 Equivocal Positive 65.7
10 76/F 2 CEI Lt. M2 Positive Positive 62.83
11 58/F 4 CEI Lt. M2 Positive Positive 146.53
12 58/M 4 CEI Lt. M2 Positive Positive 155.39
13 56/M 7 CEI Lt. PICA Equivocal Positive 64.73
14 61/M 24 A-to-A Rt. ICA Not evaluable Positive 122.75
15 66/M 22 A-to-A Lt. ICA Not evaluable Positive 317.71
16 83/M 18 A-to-A Lt. M1 Positive Positive 194.89
17 71/M 7 A-to-A Lt. M2 Positive Positive 124.12
18 67/M 4 A-to-A Lt. PICA Negative Negative –
19 63/M 3 ATI Rt. M1 Negative Negative –
20 68/M 24 ATI Rt. M1 Equivocal Negative –
21 75/F 1.5 ATI Rt. M1 Equivocal Equivocal –
22 58/M 1 ATI Lt. M1 Negative Negative None
23 67/M 18 ATI Lt. M1 Negative Negative None
24 82/M 20 ATI Rt. M2 Negative Negative None
25 84/F 20 ATI BA Negative Negative None
26 77/F 2.5 ATI Lt. PCA Equivocal Negative None
ATI, atherothrombotic infarction; A-to-A, artery-to-artery embolic infarction; BA, basilar artery; CEI, cardiogenic embolic infarction; 
F, female; ICA, internal carotid artery; lt., left; M, male; MR, magnetic resonance; MRA, MR angiography; M1, horizontal segment of 
MCA; M2, insular segment of MCA; PICA, posterior inferior cerebellar artery; rt., right; T2*WI, T2*-weighted imaging.
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Image analysis
We performed visual assessment of R2* map and T2*-
WI at steno-occluded site of MRA. We divided 4 cate-
gories according to the consensus of the 2 neuroradiolo-
gists (Y.S. and A.K., with 12 and 4 years of experience, 
respectively, in diagnostic neuroradiology) as follows: 
i) positive = definitely visible of susceptibility effect 
reflecting thrombi; ii) negative = definitely invisible of 
susceptibility effect reflecting thrombi; iii) equivocal 
= difficult to distinguish between susceptibility effect 
reflecting thrombi and other paramagnetic substances, 
and iv) not evaluable = difficult to evaluate susceptibility 
effect reflecting thrombi due to susceptibility artifacts 
arising from skull base.
 We also performed quantitative assessment of acute 
thrombi on R2* map. Regions of interest (ROI) were 
defined as areas of susceptibility effect reflecting throm-
bi on R2* map and mean R2* values of thrombi were 
measured in each patient. Each difference of R2* value 
among stroke subtypes was analyzed with Mann-Whit-
ney U test using SPSS software (version 19.0; SPSS, 
Chicago, IL). A P value < 0.05 was considered statisti-
cally significant.
RESULTS
Twenty-six patients (16 men and 10 women; mean age, 
73 years; range, 56–93 years) were enrolled in the pres-
ent study. The causes of brain infarction with intracra-
nial vessel occlusion were as follows: 13 of cardiogenic 
embolic infarction (CEI), 5 of artery-to-artery embolic 
infarction (A-to-A), and 8 of atherothrombotic infarction 
(ATI). A summary of our results is shown in Table 1.
 Both R2* map and T2*WI showed susceptibility 
effect reflecting acute thrombi at the occluded site of 
MRA in 7 patients with CEI and 2 patients with A-to-A 
(Fig. 1). R2* map enabled to show positive findings 
while T2*WI showed equivocal findings due to the sur-
rounding vessel signal intensity of thrombus in 3 patients 
with CEI (Fig. 2). Acute thrombus in terminal ICA on 
R2* map is more clearly detected than that on T2*WI (not 
evaluable) without any apparent susceptibility artifact 
from the skull base around thrombus in 2 patients with 
CEI and 2 patients with A-to-A (Fig. 3).
 Both R2* map and T2*WI indicated negative find-
ings corresponding to the occluded site of MRA in 1 
patient with CEI, 1 patient with A-to-A and 5 patients 
with ATI. R2* map showed negative findings, whereas 
T2*WI demonstrated slight hypointensity which might 
reflect the other paramagnetic substances such as artery 
itself or arterial wall calcification in 2 patients with ATI. 
The other 1 patient had equivocal finding on both R2* 
map and T2*WI.
 For quantitative assessment of susceptibility effect of 
thrombi, we could trace the margin of emboli as ROI for 
measuring R2* values (1/T2*, /msec) in 12 of 13 patients 
with CEI and 2 of 4 patients with A-to-A. Mean R2* 
values of CEI and A-to-A were 136.6 /msec and 189.9 /
msec, respectively. There were no significant differences 
between them (P = 0.332).
DISCUSSION
Our results showed that R2* map demonstrated acute 
thrombus as prominent susceptibility effect with high 
sensitivity in the patients of CEI and A-to-A embolism. 
In addition, R2* map could demonstrate susceptibility 
effect of ICA embolus, which are difficult to detect on 
conventional T2*WI due to the strong susceptibility 
artifact arising from the skull base.10, 13 Although quan-
titative R2* values of thrombi showed no significant 
difference between CEI and A-to-A, R2* map showed 
negative findings at occluded sites in ATI so that it was 
possible to distinguish between embolic and athero-
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Fig. 1D  Fig. 1. 80-year-old female with CEI in the right MCA territory (patient 4).
DWI shows restrict diffusion in the right basal ganglia (A) and MRA reveals occlusion at horizontal segment of right MCA (B). Corre-
sponding to the occlusion site of MRA, both T2*WI (C) and R2* map (D) show prominent susceptibility effect reflecting fresh thrombus 
(→). CEI, cardiogenic embolic infarction; DWI, diffusion weighted imaging; MCA, middle cerebral artery; MRA, magnetic resonance 
angiography; T2*WI, T2*-weighted imaging.
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Fig 2DFig. 2. 82-year-old male with CEI in the left MCA territory (patient 6).
DWI demonstrates high signal intensity in the left frontal cortex and insula (A) and MRA reveals occlusion at horizontal segment of left 
MCA (B). Corresponding to the occlusion site of MRA, R2* map can show prominent susceptibility effect reflecting fresh thrombus (D, 
→), while T2*WI shows equivocal findings of the susceptibility effect reflecting thrombus because of the neighboring low signal intensity 
from proximal artery itself (C, ○). CEI, cardiogenic embolic infarction; DWI, diffusion weighted imaging; MCA, middle cerebral artery; 
MRA, magnetic resonance angiography; T2*WI, T2*-weighted imaging.
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Fig. 3D Fig. 3. 66-year-old male with A-to-A embolism at left terminal ICA (patient 15).
DWI shows high signal intensity in the left occipital cortex (A) and MRA demonstrates left ICA occlusion with decreased in-flow effect 
of left MCA and left PCA (B). In this case, acute thrombus at left terminal ICA on R2* map (D) is more clearly detected than that on 
T2*WI (C), without any apparent susceptibility artifact from the skull base around thrombus. A-to-A, artery-to-artery embolic infarction; 
DWI, diffusion weighted imaging; ICA, internal carotid artery; MCA, middle cerebral artery; MRA, magnetic resonance angiography; 
PCA, posterior cerebral artery; T2*WI, T2*-weighted imaging.
thrombotic and embolic infarctions clearly.
 It has been already known that early recanalization 
rate after intravenous rtPA therapy was low in cases 
with large proximal arterial occlusions like proximal 
middle cerebral artery (MCA) and ICA.13, 21–25 On CT 
angiography, clot burden score, which is the scoring 
system of the length and location of the thrombus, was 
proposed to predict radiological and neurological out-
come for thrombolytic therapy or thrombectomy.21–25 
Although T2*WI plays an important role for detecting 
intra-arterial acute thrombus as susceptibility vessel sign 
by reflecting the presence of deoxyhemoglobin within 
the clot, susceptibility artifacts from the skull base of-
ten disturb the visibility of susceptibility vessel sign at 
ICA on T2*WI.10, 13 Therefore, our results showed the 
utility of R2* map for detecting thrombus at ICA as well 
as MCA indicate a potential of R2* map to be a novel 
additional marker predicting the efficacy of intravenous 
rt-PA or mechanical thrombectomy.21–25 Furthermore, 
since therapeutic strategy was different between embolic 
and atherothrombotic infarctions, we consider that high 
specificity of acute thrombus on R2* map also results 
in the selection of optimal therapeutic strategy for acute 
ischemic stroke.
 IDEAL IQ is a commercial software equipped with 
multi-echo chemical shift based water-fat separation 
and simultaneous R2* estimation techniques applying 
Dixon method.16–18 Using this software, quantitative iron 
image called R2* map, as well as in- and out-of-phase 
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be obtained by single scanning with short acquisition 
time.16–18 The technical aspects of IDEAL IQ, especial-
ly the short multi-echo acquisitions, lead to the fact that 
R2* map enables to distinguish slight differences of the 
T2* decay caused by susceptibility effect and visualize 
them with reliable image contrast, such as between acute 
thrombus in ICA and susceptibility artifacts arising from 
the skull base, or peripheral acute thrombus and neigh-
boring intracranial vessels and vessel wall calcifications.
 Although IDEAL IQ has been already used for 
quantitative evaluation of iron deposition and fat fraction 
of the liver,18 this is the first report that indicates a util-
ity of R2* map by using IDEAL IQ for detecting acute 
thrombus in the patients with cerebral infarction. We 
also performed quantitative evaluation of thrombus and 
no significant difference was found between CEI and 
A-to-A. Cho et al. previously reported that susceptibility 
vessels signs on T2*WI were more commonly associ-
ated with cardioembolic stroke patients than with other 
stroke subtypes including large artery atherosclerosis.8 
Liebeskind et al., on the other hand, reported that sus-
ceptibility vessel signs on T2*WI reflected histopathol-
ogy of thrombi: red blood cell-dominant thrombi deter-
mined appearance of susceptibility vessel signs, whereas 
fibrin-predominant occlusive thrombi determined ab-
sence of susceptibility vessel signs.12 However, histopa-
thology of thrombi extracted by endovascular mechani-
cal thrombectomy was unrelated to final determination 
of stroke subtypes.12 Therefore, there is not yet a unified 
view whether the susceptibility effects of thrombi on 
MR imaging enable to determine stroke subtypes or not. 
R2* map generated by IDEAL IQ is more sophisticated 
quantitative susceptibility-sensitive image than conven-
tional T2*WI. We consider that further examination of 
R2* map with larger sample size may lead to clarify its 
potential of differentiation between CEI and A-to-A.
 Our study has several limitations. First, we used 
MRA as reference standard of vessel occlusions in this 
study. MRA is less accurate as a reference for vessel 
occlusion and recanalization than catheter angiography 
although this modality has proven relatively accurate in 
evaluating vessel patency.26, 27 Second, we did not con-
sider the difference of signal intensity due to the chrono-
logical histopathological change of acute thrombus. 
However, it is likely to be less important factor than we 
thought, as long as the each interval from onset to MR 
examination was relatively short like our study. Third, 
the sample size was modest especially in the patients of 
A-to-A embolism. As mentioned previously, larger sam-
ple size will be needed to clarify the efficacy of quanti-
tative evaluation of thrombi on R2* map. 
 In conclusion, the detectability of fresh thrombus on 
R2* map is almost equal to that on T2*WI. Regarding 
distal ICA embolism, its detectability on R2* map may 
be superior to that on T2*WI. Moreover, R2* map can 
provide additional information to differentiate CEI and 
A-to-A from ATI.
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